Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Selected Balance Sheet Data

v3.10.0.1
Note 3 - Selected Balance Sheet Data
3 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Supplemental Balance Sheet Disclosures [Text Block]
N
ote
3
. Selected Balance Sheet Data
:
 
Inventories:
 
Inventories consist of (in thousands):
 
   
September 30,
   
June 30,
 
   
2018
   
2018
 
Raw materials
  $
32,082
    $
30,956
 
Finished goods
   
58,836
     
54,692
 
Inventories, net
  $
90,918
    $
85,648
 
 
 
Property and Equipment:
 
Property and equipment consist of (in thousands):
 
   
September 30,
   
June 30,
 
   
2018
   
2018
 
Land
  $
7,065
    $
7,065
 
Buildings and improvements
   
171,580
     
170,110
 
Machinery and equipment
   
115,769
     
107,625
 
Property and equipment, cost
   
294,414
     
284,800
 
Accumulated depreciation and amortization
   
(147,903
)
   
(139,452
)
Property and equipment, net
  $
146,511
    $
145,348
 
 
 
Intangible Assets:
 
Intangible assets consist of (in thousands):
 
   
September 30,
   
June 30,
 
   
2018
   
2018
 
Developed technology
  $
505,131
    $
305,303
 
Trade names
   
89,567
     
89,608
 
Customer relationships
   
212,702
     
212,228
 
Patents
   
1,707
     
1,401
 
Intangible assets
   
809,107
     
608,540
 
Accumulated amortization
   
(176,421
)
   
(162,208
)
Intangible assets, net
  $
632,686
    $
446,332
 
 
Changes to the carrying amount of net intangible assets for the quarter ended
September 
30,
2018
consist of (in thousands):
 
Beginning balance
  $
446,332
 
Acquisitions
   
200,000
 
Other additions
   
285
 
Amortization expense
   
(14,313
)
Currency translation
   
382
 
Ending balance
  $
632,686
 
 
 
The estimated future amortization expense for intangible assets as of
September 
30,
2018
is as follows (in thousands):
 
2019 remainder
  $
45,850
 
2020
   
60,475
 
2021
   
60,120
 
2022
   
58,424
 
2023
   
56,549
 
Thereafter
   
351,268
 
Total
  $
632,686
 
 
 
Goodwill:
 
Changes to the carrying amount of goodwill for the quarter ended
September 
30,
2018
consist of (in thousands):
 
   
Protein
Sciences
   
Diagnostics
and
Genomics
   
Total
 
Beginning balance
  $
347,918
     
249,972
    $
597,890
 
Acquisitions (Note 4)
   
9,790
     
96,592
     
106,382
 
Currency translation
   
537
     
(19
)
   
518
 
Ending balance
  $
358,245
    $
346,545
    $
704,790
 
 
 
We evaluate the carrying value of goodwill in the
fourth
quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a quantitative assessment for all of its reporting units during the
fourth
quarter of fiscal
2018.
The quantitative assessment indicated that all of the reporting units had substantial headroom as of
June 30, 2018.
 
No
triggering events were identified during the quarter ended
September 30, 2018.
There has been
no
impairment of goodwill since the adoption of Financial Accounting Standards Board (“FASB”) ASC
350
guidance for goodwill and other intangibles on
July 1, 2002.